Spreadsheet: f9177a8b-ad53-4381-900d-ac2bbc851774
Sheet: Sheet1

Unnamed: 0 | MISSION AND STRATEGIC GOAL INDICATORS | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6 | Unnamed: 7 | Unnamed: 8 | Unnamed: 9 | Unnamed: 10 | Unnamed: 11 | Unnamed: 12 | Unnamed: 13 | Unnamed: 14 | Unnamed: 15 | Unnamed: 16 | Unnamed: 17
 | Update: | 22/10/2014 |  | Baseline |  |  | Intermediate Targets |  |  | Aggregate |  |  | Achievement
 | S# | Category and Indicator | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2011-15 | 2011 | 2012 | 2013 | 2014 | 2015 | Trend | Data Sources
 | M | MISSION |  |  |  |  |  |  |  |  | Numbers in RED indicate Projections
 | M.1 | Under Five Mortality Rate | Per 1000 | 77 | 75 | 73 | 71 | 69 | 67 |  | 74 | 71 | 69 |  |  |  | Inter Agency Group for Child Mortality Estimation, United Nations Population Division; World Population Prospects
 | M.2 | Number of future deaths averted
 |  | Cumulative number of future deaths averted | Millions | 0 | 0.483 | 1.09 | 1.903 | 2.859 | 3.902 |  | 0.6 | 1.3 | 2.2 | 3.1 |  |  | Joint impact modelling by GAVI Alliance and [NAME] and Melinda Gates Foundation
 | M.3 | Number of children immunized | Millions | 0 | 36 | 39 | 50 | 58 | 61 | 243 | 45 | 50 | 53 |  |  |  | WHO/UNICEF National Immunization Coverage estimates, United Nations Population Division; World Population Prospects
 | SG1 | STRATEGIC GOAL 1: VACCINE GOAL
 | SG.1.a | Country introduction of vaccines (new/underused) | Cumulative Count |  |  |  |  |  |  |  |  |  |  |  |  |  | GAVI internal databse for vaccine launches
 |  | Pentavalent |  | 62 | 65 | 69 | 69 | 69 | 69 | 69 | 65 | 70 | 72 | 73*
 |  | Rotavirus |  | 4 | 5 | 16 | 23 | 28 | 33 | 33 | 5 | 12 | 18 | 32*
 |  | Pneumococcal Vaccine (PCV) |  | 3 | 19 | 32 | 35 | 36 | 45 | 45 | 16 | 24 | 38 | 44*
 | SG.1.b | Coverage of new and underused vaccines | % |  |  |  |  |  |  |  |  |  |  |  |  |  | WHO/UNICEF National Immunization Coverage estimates
 |  | Pentavalent 3rd dose |  | 0.3948 | 0.4648 | 0.5148 | 0.6548 | 0.7648 | 0.7748 |  | 0.411 | 0.428 | 0.53
 |  | Rotavirus last dose |  | 0.006778674389644202 | 0.01 | 0.05224789811951072 | 0.1399141486085491 | 0.2352547992588996 | 0.3066252361748147 |  | 0.01 | 0.03 | 0.07
 |  | Pneumococcal Vaccine (PCV) 3rd dose |  | 0.006 | 0.05 | 0.1725038471214554 | 0.29 | 0.35 | 0.4 |  | 0.049 | 0.1 | 0.19
 | SG2 | STRATEGIC GOAL 2: HEALTH SYSTEM GOAL
 | SG.2.a | DTP1 - DTP3 drop out rate | % | 0.11 | 0.11 | 0.1 | 0.1 | 0.09 | 0.09 |  | 0.11 | 0.11 | 0.11 |  |  |  | WHO/UNICEF National Immunization Coverage estimates
 | SG.2.b | DTP3 Coverage | % | 0.76 | 0.78 | 0.79 | 0.8 | 0.81 | 0.82 |  | 0.74 | 0.743 | 0.76 |  |  |  | WHO/UNICEF National Immunization Coverage estimates
 | SG.2.c | Equity in immunization | % | 0.51 |  |  |  |  | 0.62 |  | 0.51 | 0.54 | 0.57 | 57%* |  |  | DHS and MICS; other surveys that use comparable methods may be used where no DHS or MICS is conducted.
 | SG.2.d | MCV1 Coverage (new indicator added in 2013) | % | 0.761 |  |  |  |  |  |  | 0.75 | 0.75 | 0.76 |  |  |  | WHO/UNICEF National Immunization Coverage estimates
 | SG3 | STRATEGIC GOAL 3: FINANCNG GOAL
 | SG.3.a | Total resources mobilized to meet demand | $ |  | 1 | 1 | 1 | 1 | 1 |  | 1 | 1 | 1 |  |  |  | Strategic Demand Forecast v2.0 and GAVI Secretariat records of amount of resources mobilised
 | SG.3.b | Country investment in vaccines per child | $ | $3.78 | Target is equal to increase |  |  |  |  |  | $3.7 | $4.8 | - |  |  |  | WHO/UNICEF Joint Reporting Form (JRF); GAVI Annual Progress Reports; GAVI's Adjusted Demand Forecast; UNPD data
 | SG.3.c | Fullfilment of co-financing comittments | % | 0.86 | 1 | 1 | 1 | 1 | 1 |  | 0.93 | 0.86 | 0.79 |  |  |  | UNICEF Supply Division and the PAHO Revolving Fund
 | SG4 | STRATEGIC GOAL 4: MARKET SHAPING GOAL
 | SG.4.a | Total cost to fully immunise a child with Penta, Rota and PCV | $ | 35.19 |  |  |  |  |  |  | 32.97 | 22.63 | $22 |  |  |  | UNICEF Supply Division
 | SG.4.b | Security of supply (number of products offered as % of 5 year target) | % | 0.54 |  |  |  |  | 1 |  | 0.67 | 0.79 | 0.79 |  |  |  | Procurement partner manufacturer offers
 |  |  |  | NA: Not applicable |  |  |  |  |  |  |  |  |  | *as of 1 October 2014